Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025

This bill aims to protect patients and cut fraud in nerve testing paid by Medicare. It says Medicare will only pay for two tests—nerve conduction studies and needle EMG—when they are done in “qualified” facilities that are accredited by approved organizations. CMS will pick these organizations and set rules. The bill also creates a national advisory committee to help set strong standards, reduce unnecessary repeat tests and surgeries, improve diagnoses, and fight waste and abuse. An exception applies for monitoring during surgery.

To count as qualified, a facility must have a quality program, use proper equipment (able to do both nerve studies and real‑time needle EMG waveforms), ensure the person doing needle EMG has at least three months of specialized training, and have results interpreted on‑site at the time of the test. CMS will issue rules, approve accrediting groups, and can pull approval if standards aren’t met.

Key points

• Who is affected: Medicare patients getting nerve tests; doctors, physical therapists, and testing labs that provide them.
• What changes: Medicare pays only if tests are done at accredited facilities with required training, equipment, and on‑site, same‑day interpretation; surgical neuromonitoring is exempt.
• When: CMS must finish regulations within 1 year; approve accrediting groups within 2 years; set up the advisory committee within 2 years; Medicare’s “only pay at qualified facilities” rule starts on a date the Secretary sets between 3 and 4 years after the law is enacted.